Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rafael Holdings Inc (NY: RFL )

2.270 +0.090 (+4.13%)
Official Closing Price Updated: 7:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,966
Open 2.230
Bid (Size) 2.060 (20)
Ask (Size) 2.350 (54)
Prev. Close 2.180
Today's Range 2.210 - 2.270
52wk Range 1.550 - 2.740
Shares Outstanding 100
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)
From Cyclo Therapeutics, Inc.
Via Business Wire

Performance

YTD
+17.62%
+17.62%
1 Month
+18.85%
+18.85%
3 Month
+9.13%
+9.13%
6 Month
+18.85%
+18.85%
1 Year
+22.04%
+22.04%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Rafael Holdings Announces up to $5 Million Share Repurchase Program
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Top Real Estate Stocks That May Plunge
Via Benzinga
Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities
From Rafael Holdings, Inc.
Via GlobeNewswire
Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer
From Cornerstone Pharmaceuticals
Via GlobeNewswire
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
Via Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
More Than $27 Million Bet On Seres Therapeutics? 4 Penny Stocks Insiders are Buying
Via Benzinga
54 Biggest Movers From Yesterday
Via Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
86 Biggest Movers From Yesterday
Via Benzinga
66 Biggest Movers From Friday
Via Benzinga
30 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
66 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 160 Points; Wolfspeed Shares Gain After Q1 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Nasdaq Rises Over 1%; Rafael Holdings Shares Slide
Via Benzinga
Topics Stocks
Exposures US Equities
Here's Why Rafael Holdings Is Plummeting Today
Via The Motley Fool
Mid-Morning Market Update: Markets Rise; Caterpillar Profit Beats Expectations
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.